Wellfully Past Earnings Performance

Past criteria checks 0/6

Wellfully's earnings have been declining at an average annual rate of -37.1%, while the Pharmaceuticals industry saw earnings growing at 31.2% annually. Revenues have been declining at an average rate of 4.5% per year.

Key information

-37.1%

Earnings growth rate

-15.0%

EPS growth rate

Pharmaceuticals Industry Growth	31.2%
Revenue growth rate	-4.5%
Return on equity	n/a
Net Margin	-469.0%
Last Earnings Update	31 Dec 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Wellfully makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ASX:WFL Revenue, expenses and earnings (AUD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Dec 22	2	-8	7
30 Sep 22	2	-8	7
30 Jun 22	3	-7	7
31 Mar 22	2	-7	7
31 Dec 21	1	-7	7
30 Sep 21	1	-7	6
30 Jun 21	1	-6	6
31 Mar 21	1	-6	5
31 Dec 20	1	-6	5
30 Sep 20	1	-5	5
30 Jun 20	1	-4	4
31 Mar 20	2	-3	4
31 Dec 19	3	-2	4
30 Sep 19	3	-2	4
30 Jun 19	3	-2	4
31 Mar 19	2	-2	3
31 Dec 18	2	-2	3
30 Sep 18	2	-2	3
30 Jun 18	2	-2	3
31 Mar 18	2	-1	3
31 Dec 17	2	-1	2
30 Sep 17	2	-2	3
30 Jun 17	2	-3	4
31 Mar 17	2	-4	5
31 Dec 16	2	-5	5
30 Sep 16	2	-4	5
30 Jun 16	2	-4	4
31 Mar 16	2	-3	4
31 Dec 15	2	-3	3
30 Sep 15	2	-3	3
30 Jun 15	2	-2	3
31 Mar 15	1	-2	3
31 Dec 14	1	-2	3
30 Sep 14	1	-2	3
30 Jun 14	1	-2	3
31 Mar 14	1	-2	2
31 Dec 13	1	-1	2
30 Sep 13	1	-1	2
30 Jun 13	1	-1	2
31 Mar 13	1	-2	2
31 Dec 12	0	-2	2

Quality Earnings: WFL is currently unprofitable.

Growing Profit Margin: WFL is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: WFL is unprofitable, and losses have increased over the past 5 years at a rate of 37.1% per year.

Accelerating Growth: Unable to compare WFL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WFL is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-10%).

Return on Equity

High ROE: WFL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Wellfully Past Earnings Performance

Past criteria checks 0/6

Key information

Recent past performance updates

First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.019 loss in 1H 2022)

Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)

Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Recent updates

Wellfully Limited, Annual General Meeting, Apr 26, 2024

Wellfully Limited Announces Board Changes

Wellfully Limited Appoints John Forrester as Director

First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.019 loss in 1H 2022)

Wellfully Limited Appoints David Wheeler as Non-Executive Director, Effective from 1 February 2023

Wellfully Limited Announces Step Down of Steven Schapera as Non-Executive Director, Effective 31 December 2022

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Wellfully Limited Appoints Andy Wortlock as Non-Executive Director

Less than half of directors are independent

Wellfully Limited, Annual General Meeting, Nov 25, 2022

Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)

Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million.

Wellfully Limited Announces Knee Patch Registered as A Medical Device

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million.

Wellfully Limited announced that it expects to receive AUD 0.1 million in funding

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million.

Wellfully Limited Announces Board Changes

Wellfully Limited Announces Swisswell Knee Patch Successfully Registered as Medical Device in the USA

Less than half of directors are independent

Less than half of directors are independent

Wellfully Limited Announces Board Changes

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Independent Non-Executive Director Cameron Reynolds has left the company

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Wellfully Limited announced that it expects to receive AUD 4.75 million in funding

Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million.

Wellfully Limited Announces Business & Operational Update

Wellfully Limited Completes Its Scheduled Release of 20 Launches in 20 Weeks for Its RÉDUIT Brand

Full year earnings released - AU$0.041 loss per share

Wellfully Limited Signs A Content Partnership for Its RÉDUIT Brand with Victoria Beckham

Wellfully Limited Agrees to Supply Terms For, and Launches its Réduit Brand with The Hut Group

Full year earnings released

Revenue & Expenses BreakdownBeta

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Revenue & Expenses Breakdown
Beta